drugset / Trial / NCT01060475
Safety and Tolerability of LIM-0705 in Healthy Male Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
LIM-0705 dosed separately and in combination with tacrolimus will be safe and well tolerated.
Timeline
- Start
- 2010-02
- Primary completion
- 2010-05
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QUERCETIN-3'-O-PHOSPHATE | Small molecule | 500 mg | Oral |
| Subject | QUERCETIN-3'-O-PHOSPHATE | Small molecule | 750 mg | Oral |
| Subject | Tacrolimus | Small molecule | — | — |
Indications
No indication recorded.